NCCN Research & Business Resources
NCCN Oncology Research Program (ORP)
NCCN ORP Mission Statement
The NCCN ORP strives to improve the quality of life for patients and reduce cancer-related
deaths by advancing cancer therapies through research. We believe we can achieve
this goal by supporting oncology preclinical, translational, and clinical research
at NCCN Member Institutions. We recognize the importance of developing and maintaining
strong alliances with industry and actively facilitating collaborations between
academia and industry drug developers making important scientific strides in the
field of oncology. It is NCCN's vision to have the NCCN ORP become a Center for
Excellence in the United States for providing outstanding research and research
About the NCCN Oncology Research Program
The NCCN Oncology Research Program (ORP) is organized to obtain funding to support
scientifically meritorious research studies (clinical trials) at NCCN Member Institutions.
Policies and standards for the program are set by the NCCN Investigator Steering
Committee, comprised of senior research physicians appointed by each NCCN Member
Institution. The NCCN ORP has received millions of dollars in research grants from
major pharmaceutical companies to support investigator-initiated trials, which explore
new venues of clinical investigation that answer important research questions. Studies
evaluate innovative combinations and sequencing regimens of drugs, mechanisms of
action of specific agents, drug resistance, or are directed toward exploring extended
uses for specific agents.
View the NCCN ORP Press Releases
View the NCCN
ORP Scientific Publications
View the NCCN Investigator
View the NCCN ORP Testimonials
View the NCCN ORP Disclosure
Leading clinicians and investigators from NCCN Member Institutions evaluate promising
new chemical entities or biological agents.
NCCN General Poster Session
NCCN is now accepting abstracts for consideration to be presented during the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ General Poster Session at the Westin Diplomat in Hollywood, Florida on March 13 – 15, 2014.
The Abstract submission deadline is Monday, December 9, 2013.
NCCN and Pfizer, Inc. Grant Opportunity
National Comprehensive Cancer Network® (NCCN®) is pleased to announce that it is collaborating with Pfizer’s Independent Grants for Learning & Change (IGLC) team to offer a grant opportunity focused on improving care for patients with rare types of cancers such as renal cell carcinoma and certain hematologic malignancies, where treatment options are complex and rapidly advancing. The Request for Proposals (RFP) clearly outlines the scope and process that will be followed for the submission of Letters of Intent (LOIs). Submit Letter of Intent (LOI) by Thursday, December 5, 2013.
View RFP for the NCCN and Pfizer, Inc. Grant Opportunity
Members Only Section
NCCN Oncology Research Program (ORP) –
Click here if you are a clinician at an NCCN Member Institution and would
- Update your information in the Investigator Database
- View current opportunities for research grants
- View information regarding previously funded research grants
View information for the NCCN Oncology Research
Program for Industry.